Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa? (Q38947966)

7 September 2017

Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa? (English)

1 reference

7 September 2017

0 references

1 reference

I A Clark

1

1 reference

7 September 2017

F M al-Yaman

series ordinal

2

1 reference

7 September 2017

W B Cowden

series ordinal

3

1 reference

7 September 2017

K A Rockett

series ordinal

4

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

7 September 2017

1 reference

7 September 2017

348

1 reference

7 September 2017

9040

1 reference

7 September 2017

1492-1494

1 reference

Autoimmune disease and parasitic infections in Nigerians.

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Possible central role of nitric oxide in conditions clinically similar to cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Serum creatinine levels and reactive nitrogen intermediates in children with cerebral malaria in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

MALARIA INDUCED ENDOTOXIN TOLERANCE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Impairment of the immune response to vaccination after acute malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Possible role of nitric oxide in malarial immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Experimental allergic encephalitis: Study of cellular immunity during disease suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

Race and hypertension. What is clinically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907342-4

7 January 2021

10.1016/S0140-6736(96)07342-4

Identifiers

DOI

1 reference

7 September 2017

1 reference